Kestine 20 (Ebastine)

Ebastine selectively blocks peripheral H1 receptors, preventing histamine from binding to these sites on mast cells and blood vessels. This inhibition stops the cascade that leads to vasodilation, increased permeability, and nerve stimulation, thereby alleviating the classic signs of an allergic response.

The appropriate dose of Kestine 20 is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and overall health status. Physicians tailor the regimen to achieve optimal symptom control while minimizing potential side effects.

Safety data for ebastine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Kestine 20.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with first‑generation antihistamines such as diphenhydramine, ebastine causes less sedation because it does not readily cross the blood‑brain barrier. Relative to other second‑generation agents like cetirizine or loratadine, ebastine offers a similar efficacy profile with a low incidence of central nervous system effects, though individual response may vary.

Store Kestine 20 at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture, excessive heat and direct sunlight to maintain potency throughout the shelf life.

Kestine 20 is taken orally, usually with a glass of water. It can be taken with or without food; however, consistent administration with respect to meals may help maintain steady plasma levels. Swallow the tablet whole; do not crush or chew.

Serious adverse events, although rare, include cardiac arrhythmias, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, hepatotoxicity, and hematologic abnormalities. Patients should seek immediate medical attention if they experience symptoms like rash, difficulty breathing, chest pain, or unexplained jaundice.

Kestine 20 should be avoided in individuals with known hypersensitivity to ebastine or any of the tablet’s excipients. Caution is also advised for patients with severe hepatic impairment, uncontrolled cardiac disease, or those taking medications that strongly inhibit CYP3A4 without appropriate monitoring.